Skip Repeated Content

Sam Hofmeier focuses his trial and appellate practice on product liability, mass tort, and class action defense.  He assists clients through all phases of litigation, with an emphasis on legal strategy, motion practice, trial preparation, and appeals.

Sam has represented clients in state and federal courts across the country, including in multidistrict litigation.  He also has experience briefing and arguing cases in multiple state and federal appellate courts.

After graduating with a B.A. in history and political science from the University of Kansas, Sam attended the Indiana University Maurer School of Law.  Sam graduated first in his class and was a member of the Order of the Coif and the Order of Barristers.  Before joining the firm, Sam clerked for the Honorable Michael S. Kanne of the United States Court of Appeals for the Seventh Circuit in Chicago.      

Practices

Representative Experience

  • Briefed and argued appeal in the Eighth Circuit successfully defending government officials against constitutional claims related to a subpoena seeking information about misleading statements about an alleged cure for COVID-19
  • Briefed and argued appeal in Missouri Court of Appeals, Western District for national bank defending against fraudulent and negligent misrepresentation claims in connection with an international wire transfer
  • Co-authored briefs for large agricultural company in Arkansas trial and appellate courts successfully invalidating state statute on grounds that it unconstitutionally delegated the power of appointment to private parties
  • Co-authored brief for leading mortgage lender in Seventh Circuit appeal successfully confirming a judicial sale of commercial property following a foreclosure sale
  • Assisted with defense of large agricultural company in trial alleging that a popular herbicide caused cancer, resulting in defense verdict
  • Assisted large agricultural company with post-trial motions in a case alleging that a popular herbicide caused cancer, successfully eliminating several hundred million dollars of punitive damages  
  • Co-authored amici brief for leading biotechnology organizations in Tenth Circuit appeal in multi-district litigation concerning popular biologic drug